ACORDA THERAPEUTICS

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FD... A) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.

#People #Financial #Website #More

ACORDA THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Developer Platform Health Care

Founded:

1995-01-01

Address:

Hawthorne, New York, United States

Country:

United States

Website Url:

http://www.acorda.com

Total Employee:

251+

Status:

Active

Contact:

(914) 347-4300

Email Addresses:

[email protected]

Total Funding:

151.6 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager Content Delivery Network Font Awesome Apache Mobile Non Scaleable Content IPv6 ReCAPTCHA

Current Advisors List

ian-smith_image

Ian Smith Member of Board @ Acorda Therapeutics
Board_member

not_available_image

Sandra Panem Board of Directors @ Acorda Therapeutics
Board_member

Current Employees Featured

lauren-sabella_image

Lauren Sabella
Lauren Sabella Chief Commercial Officer @ Acorda Therapeutics
Chief Commercial Officer
2015-02-01

ron-cohen_image

Ron Cohen
Ron Cohen Founder, President and CEO @ Acorda Therapeutics
Founder, President and CEO
1995-01-01

burkhard-blank_image

Burkhard Blank
Burkhard Blank Chief Medical Officer & Head of R&D @ Acorda Therapeutics
Chief Medical Officer & Head of R&D
2016-01-01

denise-duca_image

Denise Duca
Denise Duca Executive Vice President, Human Resources @ Acorda Therapeutics
Executive Vice President, Human Resources
2015-01-01

Founder

ron-cohen_image

Ron Cohen

Stock Details

Company's stock symbol is NASDAQ:ACOR

Acquisitions List

Date	Company	Article	Price
2016-01-19	Biotie Therapies	Biotie Therapies acquired by Acorda Therapeutics	363 M USD
2014-09-24	Civitas Therapeutics	Civitas Therapeutics acquired by Acorda Therapeutics	525 M USD
2012-02-17	Neuronex	Neuronex acquired by Acorda Therapeutics	N/A